跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 71 条关于
“EMRELIS”
全部
71
临床试验
52
药物
5
机构
4
资讯
10
去年
FDA Grants Cancer Drug Approvals to AbbVie and MSD, AbbVie Announces $335M ADARx Partnership
去年
NeoGenomics Launches c-MET Companion Diagnostic for Advanced Non-Small Cell Lung Cancer Treatment
去年
ADC Market in NSCLC Projected to Reach $3.9 Billion by 2032, Led by AstraZeneca's Datroway
去年
AbbVie's Temab-A ADC Shows 63% Response Rate in EGFR-Mutated NSCLC Phase I Trial
去年
Telisotuzumab Vedotin Plus Osimertinib Shows Promise in TKI-Resistant NSCLC with c-MET Overexpression
9个月前
FDA Approves Five Novel Lung Cancer Therapies in 2025, Advancing Precision Medicine and Immunotherapy
去年
ADCs Transform NSCLC Treatment Landscape with Multiple FDA Approvals and Expanding Clinical Applications
8个月前
Neurelis Reports Transformational Growth with VALTOCO Expansion and Patent Extensions Through 2032
去年
Federal Court Strikes Down FDA's Narrow Interpretation of Orphan Drug Exclusivity in Neurelis v. Brenner
去年
Neurelis to Present New Data on Diazepam Nasal Spray for Seizure Management at AAN Annual Meeting